Dr. Karina H. Nakayama is an Assistant Professor in the Department of Biomedical Engineering (BME) at Oregon Health & Science University (OHSU) and holds a joint appointment in the Department of Orthopaedics & Rehabilitation. She is also the Co-Director and Chair of Admissions for the BME Graduate Program at OHSU. She also holds an affiliate appointment at the Phil and Penny Knight Campus for Accelerating Scientific Impact at the University of Oregon. The overarching scientific mission of her research group is to develop therapeutic treatments for traumatic musculoskeletal injuries using regenerative bioengineering strategies. Prior to OHSU, Dr. Nakayama received her Ph.D. in Biomedical Engineering from the University of California, with her dissertation work aimed at developing regenerative therapies for congenital kidney diseases using decellularized kidney matrices and the directed differentiation of stem cells towards renal lineages. She performed her postdoctoral work at Stanford University in the Department of Cardiothoracic Surgery working toward enhancing angiogenesis in ischemic limbs and engineering atheroprotective vascular grafts and myocardial tissues through the manipulation of spatial and mechanical properties.
Dr. Karina H. Nakayama is an Assistant Professor in the Department of Biomedical Engineering (BME) at Oregon Health & Science University (OHSU) and holds a joint appointment in the Department of Orthopaedics & Rehabilitation. She is also the Co-Director and Chair of Admissions for the BME Graduate Program at OHSU. She also holds an affiliate appointment at the Phil and Penny Knight Campus for Accelerating Scientific Impact at the University of Oregon. The overarching scientific mission of her research group is to develop therapeutic treatments for traumatic musculoskeletal injuries using regenerative bioengineering strategies. Prior to OHSU, Dr. Nakayama received her Ph.D. in Biomedical Engineering from the University of California, with her dissertation work aimed at developing regenerative therapies for congenital kidney diseases using decellularized kidney matrices and the directed differentiation of stem cells towards renal lineages. She performed her postdoctoral work at Stanford University in the Department of Cardiothoracic Surgery working toward enhancing angiogenesis in ischemic limbs and engineering atheroprotective vascular grafts and myocardial tissues through the manipulation of spatial and mechanical properties.